# Drug Repurposing for Ageing

<!-- ## Introduction -->

<!-- ### Summary of experimental studies showing ageing is malleable -->

<!-- ### Computational drug repurposing studies for ageing (and methods) -->
<!-- ### Research objectives -->

<!-- ## Methods -->

<!-- ## Results -->

<!-- ### Analysis of age‐related gene expression changes in human brains -->

<!-- ### Defining the ageing signature -->

<!-- ### Ageing signature in other tissues -->

<!-- ### Biological processes associated with the ageing signature -->

<!-- ### Identifying drugs that can mimic or reverse the ageing signature -->

<!-- #### Targets of the hits -->

<!-- #### Biological functions perturbed by the hits -->

<!-- ### Comparison of hits with other computational studies and databases of ageing -->

<!-- ## Discussion -->

<!-- ### Ageing signature and the biological relevance -->

<!-- ### Using gene expression to repurpose drugs -->

<!-- ### Identified drugs and their mechanisms of action (if known) -->

<!-- ### Causes and responses to ageing -->

<!-- ### Limitations in this work -->

<!-- ## Future Perspectives -->
